Audicin, a Finland-based neurotechnology
company developing real-time nervous system regulation tools, has raised $1.9
million in funding. The round includes private investment, follow-on backing
from Petteri Lahtela and Virpi Tuomivaara, as well as support from Business
Finland through its Deep Tech Accelerator programme. The funding brings the
company’s total capital raised to approximately $3 million.
The company develops solutions based on
brainwave entrainment, auditory engineering, and music neuroscience to support
focus, stress recovery, productivity, and sleep. Its technology delivers
real-time background listening sessions that adapt to physiological signals,
enabling continuous nervous system regulation throughout the day.
A core component of the offering is
Audicin for Apps, an SDK designed to integrate real-time regulation protocols
directly into digital health, performance, and consumer platforms. The SDK
operates passively – triggered by biometric data, time of day, or in-app
events—and integrates with wearable devices such as Oura, Apple Watch, Garmin,
and Whoop, without requiring additional hardware.
In parallel, the company is advancing a
standalone, offline Sleep Headband designed for use in environments where
mobile devices are restricted, including healthcare and defence settings. The
device delivers pre-configured recovery programmes based on low-frequency
brainwave protocols associated with deep sleep.
According to co-founder and CEO Laura Avonius, the company is focused on embedding nervous system support into
everyday environments, enabling real-time regulation without requiring
dedicated user attention, and expanding into contexts where maintaining recovery
and performance is more challenging.
Audicin is seeing early commercial
traction across sectors, including defence, performance, and wellness, with a
growing pipeline of enterprise opportunities and increasing user engagement
following recent product updates.
The funding will support the
commercialisation of Audicin’s core products, including its mobile application,
Sleep Headband, and Audicin for Apps, as well as further product development
and expansion into new use cases and markets.